| Michael Jacobs, | |
|
8901 Wisconsin Ave, Bethesda, MD 20889-0004 | |
| (301) 295-7754 | |
| Not Available |
| Full Name | Michael Jacobs |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 26 Years |
| Location | 8901 Wisconsin Ave, Bethesda, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447239793 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Reston Hospital Center | Reston, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physical Medicine Associates Ltd | 4981688835 | 69 |
| Ivyrehab Sept, Llc | 7911990908 | 1137 |
News Archive
Citing a U.N. report released in May, titled "Trends in Maternal Mortality: 1990 to 2010," which shows "the number of women worldwide dying of pregnancy and childbirth-related complications has almost halved in the last 20 years," Agnes Odhiambo, a researcher for women in Africa at Human Rights Watch, writes in this Inter Press Service opinion piece.
Even as the COVID-19 pandemic claims increasing numbers of patients, testing numbers are rising in most nations at the leading edge. However, the current reverse transcriptase-polymerase chain reaction (RT PCR) testing is often unavailable and takes up to several days for results to arrive.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, and Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company and among the top-five generic beta-lactam antibiotics manufacturers globally, today announced an agreement for Hospira to acquire Orchid's generic injectable finished-dosage form pharmaceuticals business for approximately $400 million.
Clovis Oncology, Inc. announced today that it has reached the target enrollment in its pivotal LEAP (Low hENT1 and Adenocarcinoma of the Pancreas) study of CO-101 in metastatic pancreatic cancer.
› Verified 6 days ago
| Entity Name | Physical Medicine Associates Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003884560 PECOS PAC ID: 4981688835 Enrollment ID: O20040617000167 |
News Archive
Citing a U.N. report released in May, titled "Trends in Maternal Mortality: 1990 to 2010," which shows "the number of women worldwide dying of pregnancy and childbirth-related complications has almost halved in the last 20 years," Agnes Odhiambo, a researcher for women in Africa at Human Rights Watch, writes in this Inter Press Service opinion piece.
Even as the COVID-19 pandemic claims increasing numbers of patients, testing numbers are rising in most nations at the leading edge. However, the current reverse transcriptase-polymerase chain reaction (RT PCR) testing is often unavailable and takes up to several days for results to arrive.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, and Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company and among the top-five generic beta-lactam antibiotics manufacturers globally, today announced an agreement for Hospira to acquire Orchid's generic injectable finished-dosage form pharmaceuticals business for approximately $400 million.
Clovis Oncology, Inc. announced today that it has reached the target enrollment in its pivotal LEAP (Low hENT1 and Adenocarcinoma of the Pancreas) study of CO-101 in metastatic pancreatic cancer.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Jacobs, 8901 Wisconsin Ave, Bethesda, MD 20889-0004 Ph: (301) 295-7754 | Michael Jacobs, 8901 Wisconsin Ave, Bethesda, MD 20889-0004 Ph: (301) 295-7754 |
News Archive
Citing a U.N. report released in May, titled "Trends in Maternal Mortality: 1990 to 2010," which shows "the number of women worldwide dying of pregnancy and childbirth-related complications has almost halved in the last 20 years," Agnes Odhiambo, a researcher for women in Africa at Human Rights Watch, writes in this Inter Press Service opinion piece.
Even as the COVID-19 pandemic claims increasing numbers of patients, testing numbers are rising in most nations at the leading edge. However, the current reverse transcriptase-polymerase chain reaction (RT PCR) testing is often unavailable and takes up to several days for results to arrive.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, and Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company and among the top-five generic beta-lactam antibiotics manufacturers globally, today announced an agreement for Hospira to acquire Orchid's generic injectable finished-dosage form pharmaceuticals business for approximately $400 million.
Clovis Oncology, Inc. announced today that it has reached the target enrollment in its pivotal LEAP (Low hENT1 and Adenocarcinoma of the Pancreas) study of CO-101 in metastatic pancreatic cancer.
› Verified 6 days ago